Cellectar Biosciences (CLRB) Preferred Dividend Payments (2017 - 2018)
Cellectar Biosciences (CLRB) posted Preferred Dividend Payments of $2.2 million for Q3 2018, up 54.72% sequentially from $1.4 million in Q4 2017.
Cellectar Biosciences (CLRB) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Cellectar Biosciences has reported Preferred Dividend Payments for 2 years, with the latest figure at $2.2 million in Q3 2018.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $2.2 million in Q3 2018, while the trailing twelve-month figure through Dec 2018 was $3.7 million (changed N/A YoY) and the FY2018 annual result came in at $2.2 million, up 54.72% from the prior year.
- Preferred Dividend Payments climbed to $2.2 million in Q3 2018 per CLRB's latest filing, from $1.4 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $2.2 million in Q3 2018 and troughed at $1.4 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 2.24 Mn |
| Dec 31, 2017 | 1.45 Mn |